ONCOCROSS

Company
Business Areas
Technology Platform
- RAPTOR AI® VERSION 2.0
- ONCOfind AI ®
Pipeline
News/IR
OncoMaster

CONTACT US

KR
EN

Company
Business Areas
Technology Platform
- RAPTOR AI® VERSION 2.0
- ONCOfind AI ®
Pipeline
News/IR
OncoMaster

KR
EN

CONTACT US

Main
News/IR
Disclosure Information

Disclosure Information

35 Posts

Outcomes of Annual Meeting of Shareholders (2025)

03-28-2025
Change of CEO

03-28-2025
Annual Report (2024.12)

03-20-2025
Submission of Audit Report

03-20-2025
Announcement of Convocation of General Meeting of Shareholders (2025)

03-13-2025
Reporting reasons for holding general shareholders' meeting on the most concentrated date

03-13-2025
Resolutions for Convocation of General Meeting of Shareholders (2025)

03-13-2025
Report on Significant Holdings of Stocks, etc.

02-12-2025
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)

02-12-2025
Report on Significant Holdings of Stocks, etc.

02-03-2025
Report on Significant Holdings of Stocks, etc.

02-03-2025

1
2
3

Please enter a prompt

CEO: Yi Rang KIM / Jihoon KANG

Address: Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)

Tel: 02-717-9967

Fax: 02-867-9968

Email: oncocross@oncocross.com

Terms & Conditions Privacy Policy Cookie Policy

ⓒ ONCOCROSS CO., LTD. All Rights Reserved.